10.5152/nsn.2019.11632 66 RubioC.Rubio-OsornioM.Retana-MrquezS.LpezM.CustodioV.PazC
FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions
We are entering a new era of obesity care where patients want individualized treatment plans that address their needs and provide choices, including oral formulations, said Anna Windle, PhD, Senior Vice President, Clinical Development, Medical & Regulatory Affairs at Novo Nordisk Inc, in a May 2, 2025, statement
Stenotic vessels likely predispose to and lower the threshold for developing increased ICP, especially in these circumstances (ie, cerebral venous stenosis, cerebral venous sinus thrombosis)
ACS Nano 13 (10), 1144311452